|
|
Medtronic's CD HORIZON BalanC spinal system receives CE Mark |
|
|
| Implants
: 23 March, 2012 |
|
Medtronic receives the CE Mark for the CD HORIZON BalanC Spinal System and is launching the product internationally to expand the options for physicians outside the United States in treating multi-level spinal surgeries requiring fusion at one or more levels and neutral stabilization (non fusion) at an adjacent level for common spine conditions such as spinal stenosis and early stage degenerative disc disease. |
| |
|
|
|
 |
|
|
|
Partners create the IHA's first automated bundled payment model |
|
|
|
| Financial software
: 23 March, 2012 |
|
McKesson is collaborating with Aetna and Hoag Orthopedic Institute of Orange County, California, to create the first automated implementation of the Integrated Healthcare Association's (IHA's) bundled payment model. |
| |
|
|
|
|
|
|
|
Macrogen invests in Illumina sequencing systems to boost capacity |
|
|
|
| DNA sequencing equipment
: 23 March, 2012 |
|
Macrogen, a global sequencing services company based in Korea, purchases an additional ten Illumina HiSeq 2000 systems and two MiSeq systems, as well as HiSeq 2500 upgrades to support a strategic scale-up that expands Macrogen's capacity with Illumina's sequencing systems and will be completed by the end of 2012. |
| |
|
|
|
|
|
|
|
|
|
Optical fluorescence sensor shows continuous glucose monitoring benefits |
|
|
|
| Glucose monitoring equipment
: 23 March, 2012 |
|
GlySure, a developer of in-hospital continuous blood glucose monitoring systems, is revealing that clinical trial data shows that an optical fluorescence sensor can successfully measure blood glucose levels with a high degree of accuracy across a wide range of intensive care patients throughout their length of stay in the ICU. |
| |
|
|
|
|
|
|
|
Cardiac Mapping software release improves workflow efficiencies in EP labs |
|
|
|
| Cardiac devices and equipment
: 23 March, 2012 |
|
St Jude Medical is launching worldwide the company's EnSite Velocity System Version 3.0 software which is designed to help shorten procedure times for patients undergoing electrophysiology (EP) procedures guided by a cardiac mapping system and improve workflow efficiencies in the EP lab. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New TAL effector proteins offer precise genome editing benefits |
|
|
|
| DNA sequencing equipment
: 21 March, 2012 |
|
Life Technologies is launching GeneArt Precision TALs, generally referred to as TAL effector proteins (TALE), which will allow researchers the ability to edit genomes and control gene activity with unprecedented precision and reliability. |
| |
|
|
|
|
|
|
|
|
|
Covidien agrees to acquire superDimension |
|
|
|
| Endoscopy equipment and services
: 21 March, 2012 |
|
Covidien signs a definitive agreement to acquire superDimension, a private company based in Herzliya, Israel, that develops minimally invasive interventional pulmonology devices. |
| |
|
|
|
|
|
|
|
NPL acquires new brachytherapy afterloader |
|
|
|
| Radiosurgery and radiotheraphy equipment
: 20 March, 2012 |
|
The National Physical Laboratory (NPL), the United Kingdom's national measurement institute, acquires a Flexitron afterloader from Nucletron, an Elekta company which will enable NPL to continue to offer its brachytherapy calibration service. |
| |
|
|
|
|
|
|
|
CareFusion agrees new distribution deal with InterMetro Industries |
|
|
|
| Pharmacy and medication equipment
: 20 March, 2012 |
|
CareFusion completes a new agreement outside the USA with InterMetro Industries to distribute the Metro brand of medication and supply management carts, including the popular 1760Rx Hybrid Medication Workstation and FlexLine Procedure cart.
|
| |
|
|
|
|
|
|
|
Bridge-to-transplant clinical trial adds additional patients |
|
|
|
| Cardiac devices and equipment
: 20 March, 2012 |
|
The US Food and Drug Administration (FDA) approves an IDE (Investigational Device Exemption) Supplement that allows HeartWare International to enroll a fourth allotment, of 54 additional patients, in its ADVANCE bridge-to-transplant clinical trial under a Continued Access Protocol (CAP). |
| |
|
|
|
|
|
|
|
Solos Endoscopy launches new endoscopic instrument solutions |
|
|
|
| Endoscopy equipment and services
: 20 March, 2012 |
|
Solos Endoscopy is launching a new endoscopic instrument line, SteriTAP which are designed to be the ultimate sterile 'take a part' endoscopic instruments of its kind and will be marketed and sold worldwide by Solos Endoscopy. |
| |
|
|
|
|
|
|
|
First patient enrolls in study for DBS in patients with refractory epilepsy |
|
|
|
| Neuroscience equipment
: 20 March, 2012 |
|
A patient from Kempenhaeghe-Heeze in The Netherlands is the first patient to be enrolled into the MORE (MedtrOnic Registry for Epilepsy) Registry which is designed to look at the long-term efficacy, quality of life impact and safety of deep brain stimulation (DBS) in patients with refractory epilepsy. |
| |
|
|
|
|
|
|
|
UPMC pathology study scores Barco Coronis Fusion display highly |
|
|
|
| Displays and monitors
: 20 March, 2012 |
|
A scientific study conducted by the University of Pittsburgh Medical Center's (UPMC) pathology department ranks Barco's Coronis Fusion 6MP DL medical display as number one in image quality and diagnostic confidence, outscoring other display modalities in a side-by-side comparison that also included consumer displays and medical displays, when viewing whole slide images. |
| |
|
|
|
|
|
|
|
|
|
Post-market study focuses on intra-operative radiation therapy |
|
|
|
| Radiosurgery and radiotheraphy equipment
: 19 March, 2012 |
|
iCAD is launching a post-market study to assess the safety and efficacy of the company's FDA-cleared Xoft Axxent eBx System when used for single-fraction, intra-operative radiation therapy (IORT) at the time of lumpectomy for early stage breast cancer.
|
| |
|
|
|
|
|
|
|
Study focuses on FCH to control bleeding during aortic aneurysm surgery |
|
|
|
| Blood transfusion equipment
: 19 March, 2012 |
|
CSL Behring reveals that the first patient has been treated as part of the REPLACE Phase III clinical trial evaluating the efficacy and safety of fibrinogen concentrate (Human) (FCH) in controlling microvascular bleeding during aortic aneurysm surgery. |
| |
|
|
|
|
|
|
|
|
|
|
|
S3 Group supports major chronic disease management programme |
|
|
|
| Telemedicine and telehealth equipment
: 19 March, 2012 |
|
S3 Group, a global enabler of scalable chronic disease management programmes, reveals that Telbios, technical and service provider of Buongiorno CReG, Europe's largest chronic disease service, has chosen them to provide design and consultancy services to enable the launch of the service in four health trust areas of Milano, Como, Bergamo and Milano-2. |
| |
|
|
|
|
|
|
